Dr. Reddy's Laboratories
RDY
#1699
Rank
$11.86 B
Marketcap
$14.19
Share price
0.35%
Change (1 day)
-1.32%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $2.02 Billion USD

According to Dr. Reddy's Laboratories's latest financial reports the company's total liabilities are $2.02 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dr. Reddy's Laboratories - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31$1.82 B42.09%
2024-03-31$1.28 B16.02%
2023-03-31$1.10 B-17.93%
2022-03-31$1.34 B6.73%
2021-03-31$1.26 B23.11%
2020-03-31$1.02 B-16.45%
2019-03-31$1.22 B-19.39%
2018-03-31$1.52 B3.12%
2017-03-31$1.47 B23.34%
2016-03-31$1.19 B-10.62%
2015-03-31$1.33 B1.18%
2014-03-31$1.32 B3.3%
2013-03-31$1.28 B5.05%
2012-03-31$1.22 B10.64%
2011-03-31$1.10 B31.45%
2010-03-31$0.83 B1.57%
2009-03-31$0.82 B-13.54%
2008-03-31$0.95 B-7.18%
2007-03-31$1.02 B-1.01%
2006-03-31$1.03 B442.51%
2005-03-31$0.19 B48.65%
2004-03-31$0.12 B44.35%
2003-03-31$89.31 M24.36%
2002-03-31$71.81 M-49.27%
2001-03-31$0.14 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
$115.63 B 5,609.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$32.60 B 1,509.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
$61.28 B 2,926.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
$62.53 B 2,987.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
$66.02 B 3,160.23%๐Ÿ‡ซ๐Ÿ‡ท France